Screening for genetic diseases & chromosomal defects with a single biopsy improves pregnancy rates

June 13, 2017, European Society of Human Reproduction and Embryology
Sequence of pictures showing a biopsy being taken from a blastocyst. Credit: Centre for Reproductive Medicine, European Hospital, Rome

Couples who are undergoing pre-implantation genetic diagnosis (PGD) in order to avoid transmission of inherited diseases, such as Duchenne muscular dystrophy or cystic fibrosis, should also have their embryos screened for abnormal numbers of chromosomes at the same time, say Italian researchers.

By doing this, only embryos that are free not only of the genetic disease, but also of chromosomal abnormalities (aneuploidy), would be transferred to a woman's womb, giving her the best chance of achieving a successful pregnancy, and avoiding the risk of implantation failure, miscarriage, or even live births that could be affected by conditions such as Down syndrome (in which there is an extra chromosome) or Turner syndrome (in which a girl has only one x chromosome rather than the normal two).

In a study reporting on the world's largest series of double genetic tests, which is published today (Tuesday) in Human Reproduction, one of the world's leading journals, the researchers carried out simultaneous PGD and pre-implantation genetic screening (PGS) on cells taken in a single biopsy.

They took between five and ten cells from the outer layer of 1122 blastocysts (the early collection of cells that begin to form about five days after an egg has been inseminated with sperm and which go on to develop into an embryo) and, after PGD and PGS, 218 blastocysts were transferred to the women's wombs, resulting in 99 pregnancies and the birth of 70 healthy babies by January 2017, when the paper was written. This is a pregnancy rate of 49%, which is higher than the average clinical pregnancy rate of between 22-32% reported in the general population of couples undergoing in vitro fertilisation (IVF). At the time of writing the paper, 13 further pregnancies were ongoing and now 12 have resulted in the birth of healthy babies, while one miscarried. This gives a delivery rate of 38.6%. A total of 91 healthy blastocysts remain frozen awaiting transfer.

Dr Maria Giulia Minasi, laboratory director at the Centre for Reproductive Medicine, European Hospital, Rome, Italy, and first author of the study, said: "Importantly, we found that while 55.7% of the biopsied blastocysts did not carry a genetic disease or changes in the structures of chromosomes, only 27.5% of them also had the right number of chromosomes. Without performing pre-implantation genetic screening for aneuploidy, 316 blastocysts, which appeared to be healthy but had abnormal numbers of chromosomes, could have been transferred, leading to implantation failures, miscarriages or sometimes live births of babies affected by aneuploidy. For the couples involved, and particularly the women, these outcomes can be emotionally devastating."

As a result of their findings, Dr Minasi and her colleagues believe that when couples undergo PGD, they should also have PGS.

Co-author, Dr Ermanno Greco, director of the Centre for Reproductive Medicine, said: "Patients who have the risk of transmitting genetically inheritable diseases to their offspring need to have preimplantation genetic diagnosis and therefore a biopsy of the blastocyst has to be performed. We strongly believe that in these cases it should be mandatory to analyse also the chromosomal status of the blastocyst, because it is possible to perform both analyses on the same biopsy sample, without performing other dangerous and invasive procedures on the embryo, or, indeed, on the growing foetus in the womb."

Both PGD and PGS are techniques that are carried out in fertility centres already, and so it would be possible for clinics to implement the researchers' recommendations now.

However, Dr Minasi said that couples should be counselled carefully so that they understand that by screening for both genetic and , there will be more occasions when it is not possible to transfer an embryo.

"We found a higher than expected rate of cycle cancellation, with 40% of cycles not having transferable blastocysts available. This can happen when there is a poor fertilisation rate or poor embryo development, and also when there are no healthy blastocysts available for transfer after PGD and PGS," she said. This cancellation rate compares with a rate of 12.2% in 2016 when the combination of PGD and PGS was not performed.

Performing PGD and PGS is not technically difficult. The woman's egg is inseminated with sperm via intracytoplasmic sperm injection (ICSI) and then cultured in the laboratory. When the blastocyst has started to form and the inner cell mass, which eventually develops into the foetus, has become clearly identifiable, the fertility specialists extract 5-10 cells from the outer layer (the trophectoderm). This procedure does not impair the implantation potential of the developing blastocyst, unlike more invasive biopsies. In this study, the researchers sent the cells from the Centre for Reproductive Medicine, where they were treating the women, to the GENOMA Molecular Genetics Laboratory in Rome for the genetic analysis.

"Performing the analyses on cells taken from only one biopsy avoids the need for a second biopsy that can be potentially dangerous to the blastocyst and could influence the embryo's developmental and implantation potential," explained co-author, Dr Francesco Fiorentino, who is director of the GENOMA laboratory.

Dr Minasi concluded: "The European Society of Human Reproduction and Embryology PGD Consortium has reported that only 28% of transferred after PGD lead to pregnancy. Our study demonstrates that PGD/PGS-based IVF is able to increase the embryo implantation rate up to nearly 48% and in this study we obtained an overall clinical pregnancy rate of 49% per embryo transfer."

Explore further: Mitochondrial DNA levels as a marker of embryo viability in IVF

More information: Maria Giulia Minasi et al, Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach, Human Reproduction (2017). DOI: 10.1093/humrep/dex215

Related Stories

Mitochondrial DNA levels as a marker of embryo viability in IVF

July 4, 2016
Despite the claims and counter-claims for new embryo assessment techniques introduced over the past two decades, the search for the holy grail of assisted reproduction - the key to the embryo destined to implant - continues. ...

Breakthrough for IVF?

May 16, 2013
Elsevier today announced the publication of a recent study in Reproductive BioMedicine Online on 5-day old human blastocysts showing that those with an abnormal chromosomal composition can be identified by the rate at which ...

New assessment reveals value of second embryo biopsy for women of advanced maternal age

November 7, 2012
An elegant new study confirms that the most commonly used method of screening for embryo abnormalities following in vitro fertilization (IVF) does accurately predict the success of embryo transplantation for younger women, ...

Sampling of embryonic DNA after IVF without biopsy

April 2, 2013
New study published in Reproductive Biomedicine Online shows that fluid-filled cavity in 5-day old human blastocysts may contain DNA from the embryo, allowing diagnosis of genetic disease without a biopsy

Recommended for you

Air pollutants linked to abnormal fetal growth

February 23, 2018
Chinese mothers who were exposed to a high level of certain air pollutants during pregnancy had a higher risk of abnormal fetal growth, according to a new Yale School of Public Health (YSPH) study.

Scientists discover critical molecular biomarkers of preeclampsia

February 21, 2018
Preeclampsia, a sudden pregnancy complication that can interfere with the blood flow to the placenta and possibly to the fetus, can lead to low birth weight, prematurity and even death. It is also a leading cause of maternal ...

Transgender women can breastfeed, first case study shows

February 16, 2018
The first scientific case study has been published describing how a US transgender woman was able to breastfeed her adopted infant by taking hormones that induce lactation.

Controversial pregnancy test drug shows deformities in zebrafish embryos within hours of exposure

February 13, 2018
The components of a controversial drug, allegedly linked to birth defects in the 1960s and '70s, caused deformations to fish embryos just hours after they received a dose in new studies by researchers at the University of ...

Direct link between glands and implanting embryos critical to pregnancy

February 9, 2018
Researchers used 3D imaging with molecular testing to uncover new insight into the earliest stages of mammalian pregnancy—offering clues to unsolved questions in pregnancy.

Lab-grown eggs could pave way towards new fertility treatments

February 8, 2018
Human eggs have been fully grown in a laboratory, in a move that could lead to improved fertility treatments.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.